Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All CareTrust REIT, Inc. filings on SEC EDGAR ↗
CareTrust REIT, Inc. has updated its investor presentation and made it available on the company's website. The filing was made under Item 7.01 (Regulation FD Disclosure) to provide current information to investors and analysts.
CareTrust REIT entered into forward sale agreements for 19,550,000 shares of common stock at an initial forward price of $36.00 per share. The transaction includes an initial 17,000,000 shares and the full exercise of an underwriters' option for an additional 2,550,000 shares. The company intends to physically settle the agreements for cash proceeds by November 12, 2027, to fund future acquisitions and for general corporate purposes.
Value
$704M
Counterparty
BofA Securities, Inc. and Morgan Stanley & Co. LLC
CareTrust REIT delivered record $2.9 billion year-to-date investments and 20% FFO growth, anchored by a strategic UK expansion through L&T and robust skilled nursing lease coverage of 2.62x.
CareTrust REIT reported Q3 2026 financial results with Normalized FFO per share increasing 20% year-over-year to $0.54. The company highlighted record year-to-date investment activity of $2.9 billion, including the initial closing of a major £1.1 billion U.K. care home portfolio acquisition from LNT Care Developments.
“Normalized FFO per share increased 20% year-over-year and the team set another record of approximately $2.9 billion invested across skilled nursing, SHOP, and UK care homes, all while positioning the balance sheet for continued strong growth in the near to mid-term.”
Dave Sedgwick, Chief Executive Officer
“The CareTrust flywheel continues to accretively deliver year-over-year growth of our asset base and FFO. The relationship with LNT is a multiplier to our SHOP and UK care home growth engines. We've never been more excited for the runway ahead.”
CareTrust REIT reported significant growth for the nine months ended September 30, 2026, with total revenues increasing to $480.5 million from $341.5 million in the prior year period. Net income attributable to the company rose to $252.9 million, supported by substantial real estate investment activity and common stock issuances that increased total assets to $7.7 billion.
CareTrust REIT $1.2B Debt Financing with KeyBank National Association
CareTrust REIT entered into a fourth amended and restated credit agreement providing for a $2.0 billion unsecured revolving credit facility and $1.2 billion in total term loans. The new arrangement includes a $700 million new term loan maturing in 2032 and an existing $500 million term loan maturing in 2030. Proceeds will be used to refinance existing debt, fund investments, and for general corporate purposes.
CareTrust REIT Signs $1.43B M&A Deal with LNT Care Developments Holdings Limited
CareTrust REIT completed the acquisition of 24 UK care homes for approximately $764 million and entered into an agreement to acquire an additional 21 in-development care homes for approximately $669 million. The transaction with LNT Care Developments includes a strategic pathway to transition the properties into a senior housing operating portfolio (SHOP) structure upon stabilization. The total investment of approximately £1.1 billion is expected to be accretive to normalized FFO and generate stabilized yields in the mid- to high-7% range.
Value
$1.43B
Counterparty
LNT Care Developments Holdings Limited
Term
through Dec 2027
“The chance to build a close relationship with LNT—one of the most productive and proven care home developers in the United Kingdom—while doing it in a way that is accretive rather than dilutive as the homes lease up, and with a defined path into a SHOP structure upon stabilization, is what makes this check all the boxes for us.”
James Callister, CareTrust’s Chief Investment Officer
“This also materially improves the age, quality and configuration of our overall UK care home portfolio.”
James Callister, CareTrust’s Chief Investment Officer